Details of the Drug Formulaction

General Information of Drug Formulation (ID: F10706)

• Formulation Name: Irbesartan 300 mg tablet
• Company: Teva Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Irbesartan	(DMTP1DC)	Diabetic kidney disease	GB61.Z	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Carmellose sodium	(E00625)	Not Available	Disintegrant
Magnesium stearate	(E00208)	11177	lubricant
Poloxamer 188	(E00645)	Not Available	Emulsifying agent; Solubilizing agent; Surfactant
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Vinylpyrrolidone	(E00668)	Not Available	Binding agent; Coating agent; Disintegrant; Film/membrane-forming agent; Solubilizing agent; Suspending agent